Yin Heyong, Wang Yu, Sun Zhen, Sun Xun, Xu Yichi, Li Pan, Meng Haoye, Yu Xiaoming, Xiao Bo, Fan Tian, Wang Yiguo, Xu Wenjing, Wang Aiyuan, Guo Quanyi, Peng Jiang, Lu Shibi
Institute of Orthopedics, Chinese PLA General Hospital, 28th Fuxing Road, Beijing 100850, PR China; School of Medicine, Nankai University, 94th Weijin Road, Nankai District, Tianjin 300071, PR China.
Institute of Orthopedics, Chinese PLA General Hospital, 28th Fuxing Road, Beijing 100850, PR China.
Acta Biomater. 2016 Mar;33:96-109. doi: 10.1016/j.actbio.2016.01.024. Epub 2016 Jan 21.
We propose a method of preparing a novel cell carrier derived from natural cartilage extracellular matrix (ECM), designated cartilage ECM-derived particles (CEDPs). Through a series of processes involving pulverization, sieving, and decellularization, fresh cartilage was made into CEDPs with a median diameter of 263 ± 48 μm. Under microgravity culture conditions in a rotary cell culture system (RCCS), bone marrow stromal cells (BMSCs) can proliferate rapidly on the surface of CEDPs with high viability. Histological evaluation and gene expression analysis indicated that BMSCs were differentiated into mature chondrocytes after 21 days of culture without the use of exogenous growth factors. Functional cartilage microtissue aggregates of BMSC-laden CEDPs formed as time in culture increased. Further, the microtissue aggregates were directly implanted into trochlear cartilage defects in a rat model (CEDP+MSC group). Gait analysis and histological results indicated that the CEDP+MSC group obtained better and more rapid joint function recovery and superior cartilage repair compared to the control groups, in which defects were treated with CEDPs alone or only fibrin glue, at both 6 and 12 weeks after surgery. In conclusion, the innovative cell carrier derived from cartilage ECM could promote chondrogenic differentiation of BMSCs, and the direct use of functional cartilage microtissue facilitated cartilage regeneration. This strategy for cell culture, stem cell differentiation and one-step surgery using cartilage microtissue for cartilage repair provides novel prospects for cartilage tissue engineering and may have further broad clinical applications.
We proposed a method to prepare a novel cell carrier derived from natural cartilage ECM, termed cartilage ECM-derived particles (CEDPs), which can support proliferation of MSCs and facilitate their chondrogenic differentiation. Further, the direct use of functional cartilage microtissue of MSC-laden CEDP aggregates for cartilage repair in vivo induced hyaline-like articular cartilage repair. This strategy for cell culture, stem cell differentiation and the one-step surgery for cartilage repair provide novel prospects for cartilage tissue engineering and may have further broad clinical applications.
我们提出了一种制备源自天然软骨细胞外基质(ECM)的新型细胞载体的方法,将其命名为软骨ECM衍生颗粒(CEDP)。通过粉碎、筛分和脱细胞等一系列过程,将新鲜软骨制成了中位直径为263±48μm的CEDP。在旋转细胞培养系统(RCCS)的微重力培养条件下,骨髓基质细胞(BMSC)能够在CEDP表面快速增殖且活力高。组织学评估和基因表达分析表明,在不使用外源性生长因子的情况下,培养21天后BMSC可分化为成熟软骨细胞。随着培养时间的增加,负载BMSC的CEDP形成了功能性软骨微组织聚集体。此外,将这些微组织聚集体直接植入大鼠模型的滑车软骨缺损处(CEDP+MSC组)。步态分析和组织学结果表明,与仅用CEDP或仅用纤维蛋白胶治疗缺损的对照组相比,在术后6周和12周时,CEDP+MSC组获得了更好、更快的关节功能恢复以及更优的软骨修复效果。总之,源自软骨ECM的创新细胞载体可促进BMSC的软骨形成分化,功能性软骨微组织的直接应用促进了软骨再生。这种用于细胞培养、干细胞分化以及使用软骨微组织进行软骨修复的一步手术策略为软骨组织工程提供了新的前景,可能具有更广泛的临床应用。
我们提出了一种制备源自天然软骨ECM的新型细胞载体的方法,即软骨ECM衍生颗粒(CEDP),它能够支持MSC的增殖并促进其软骨形成分化。此外,将负载MSC的CEDP聚集体的功能性软骨微组织直接用于体内软骨修复可诱导透明样关节软骨修复。这种用于细胞培养、干细胞分化以及软骨修复的一步手术策略为软骨组织工程提供了新的前景,可能具有更广泛的临床应用。